MRVI — Maravai Lifesciences Holdings Share News
0.000.00%
Last trade - 00:00- $1.84bn
- $2.09bn
- $185.74m
Maravai LifeSciences Q2 revenue beats estimates on strong TriLink demand
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Q1 revenue rises on higher CleanCap sales
Brief: Maravai LifeSciences Q1 Revenue USD 65.8 Million Vs. IBES Estimate USD 53 Million
Maravai LifeSciences Q4 revenue drops less than expected
Maravai LifeSciences Q3 revenue misses estimates on weakness in nucleic acid segment
Maravai LifeSciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Maravai Q2 adjusted EPS misses estimates
Brief: Maravai LifeSciences Appoints Rajesh Asarpota As Chief Financial Officer
Brief: Maravai Lifesciences Appoints Bernd Brust As CEO & Member Of Its Board Of Directors
Maravai LifeSciences Holdings Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Maravai LifeSciences Q1 Adjusted EBITDA USD -10.5 Million
Maravai LifeSciences Holdings Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: Maravai Lifesciences Holdings Inc Outlook 2025 Revenue $185.0 Million To $205.0 Million
Maravai LifeSciences Holdings Inc reports results for the quarter ended December 31 - Earnings Summary
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Brief: Maravai Lifesciences Holdings Inc Files For Non-Timely 10-K With The U.S. SEC